Concepedia

Finith E. Jernigan

FE

Statistics

Publications

13

Citations

500

H-Index

12

Active since

2010

Affiliations

Beth Israel Deaconess Medical Center(Current)

Harvard University

University of North Carolina at Chapel Hill

Cancer Research Institute

Finith E. Jernigan is an author at Beth Israel Deaconess Medical Center specializing in medicinal chemistry, drug discovery, and biochemistry.

ORCID

Publications per year

2010–2022

13

Publications

13

Synthesis and anticancer activity of novel water soluble benzimidazole carbamates

Jae Eun Cheong, Michela Zaffagni, Ivy Chung et al. · European Journal of Medicinal Chemistry · 2017 · 115 citations

, , +10

Design and synthesis of emodin derivatives as novel inhibitors of ATP-citrate lyase

Steffi Koerner, Jun‐ichi Hanai, Sha Bai et al. · European Journal of Medicinal Chemistry · 2016 · 86 citations · Full text

, , +9

Suborganelle Sensing of Mitochondrial cAMP-Dependent Protein Kinase Activity

Richard S. Agnes, Finith E. Jernigan, Jennifer R. Shell et al. · Journal of the American Chemical Society · 2010 · 72 citations

, , +17

Modulation of lymphocyte-mediated tissue repair by rational design of heterocyclic aryl hydrocarbon receptor agonists

Jiaxuan Chen, Carolyn A. Haller, Finith E. Jernigan et al. · Science Advances · 2020 · 55 citations · Full text

, , +17

Novel synthetic chalcones induce apoptosis in the A549 non-small cell lung cancer cells harboring a KRAS mutation

Yiqiang Wang, Andreas Hedblom, Steffi Koerner et al. · Bioorganic & Medicinal Chemistry Letters · 2016 · 29 citations · Full text

, , +10

1–5 of 13